US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.70

-3.5908-0.20%

Number of Gainers:2

Number of Losers:17

Number of Flat:- -

PE:- -

High:1,844.83

Open:1,843.77

Low:1,825.88

Close:1,835.29

Volume:94.01M

Turnover:5.53B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy

THOMSON REUTERS

Lakeland Unit Wins Follow-on Hong Kong Government Flying Service Foul Weather Gear Contract

Corvus Pharma to Present at Cantor Global Healthcare Conference

Lakeland Fire + Safety Secures Second Consecutive Contract for Foul Weather Gear with the Hong Kong Government Flying Service for Pilots and Engineering Officers

THOMSON REUTERS

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

AstraZeneca's New Lung Treatment Could Become Market Leader

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

NYSE Most Active Issues

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Novavax to Present at Cantor Global Healthcare Conference in Fireside Chat

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1831.6982,"timestamp":1789070399999,"preClose":1835.2891,"halted":0,"volume":94009177,"delay":0,"changeRate":-0.001957,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-3.59082,"latestTime":"09-10 16:00:00 EDT","open":1843.7695,"high":1844.8345,"low":1825.875,"amount":5529355059.635893,"amplitude":0.010331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.81388,"peRate":46.873968,"turnoverRate":0.006776,"increases":2,"decrements":17,"flats":0,"marketCap":1489973728402,"floatMarketCap":1456164959030},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1844.8345,"amplitude":0.010331,"preClose":1835.2891,"low":1825.875,"pbRate":"4.81388","latestPrice":1831.6982,"volume":94009177,"delay":0,"open":1843.7695,"prevYearClose":1637.1339,"prevWeekClose":1896.2245,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1903.6779,"twentyDayClose":1769.2863,"sixtyDayClose":1652.1289,"secType":"PLATE","market":"US","turnoverRate":0.006776,"peRate":46.873968,"marketCap":1489973728402,"floatMarketCap":1456164959030,"timestamp":1789070399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":2,"down":17,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664872684","title":"Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872684?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:55","pubTimestamp":1788440102,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL1N44V0G3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU0868494617.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU0321505868.SGD","MDCX","LU1894683348.USD","BK4588","LU0225771236.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4007","LU0306807586.USD","LU1057294990.SGD","OZEM","LU1894683264.USD","BK4568","LU1066051498.USD","SG9999002224.SGD","LU0122379950.USD","IE00B19Z3581.USD","LU0306806265.USD","SG9999003800.SGD","BK4550","IE00BBT3K403.USD","LU0321505439.SGD","LU0225284248.USD","SG9999013999.USD","BK4534","BK4599","LU0170899867.USD","BK4533","PFE","SG9999001176.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1023059063.AUD","BK4581","LU0234572021.USD","IE00B3T34201.USD","BK4592","LU1066053197.SGD","BK4139","SG9999011175.SGD","IE0002270589.USD","BK4585","LU0456855351.SGD","IE00BLSP4239.USD","LU2596442595.SGD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664742748","title":"Lakeland Unit Wins Follow-on Hong Kong Government Flying Service Foul Weather Gear Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2664742748","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664742748?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:33","pubTimestamp":1788438792,"startTime":"0","endTime":"0","summary":"Lakeland unit wins follow-on Hong Kong Government Flying Service foul weather gear contractLakeland Industries’ LHD Group Hong Kong unit won a second consecutive Government Flying Service contract for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1CdMHp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LAKE","SG9999014021.USD","IE00BKPKM429.USD","IE0031619046.USD","IE00B7SZL793.SGD","SG9999014005.SGD","BK4568","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BN0W2W23.USD","BK4585","LU0314104364.USD","SG9999014039.USD","BK4112","IE00BQXX3C00.GBP","IE00B19Z4B17.USD","LU2210150020.SGD","LU2095319765.USD","IE00BQXX3F31.USD","BK4588","IE00B66KJ199.SGD","BCDF","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BK4202","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664742588","title":"Corvus Pharma to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664742588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664742588?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:31","pubTimestamp":1788438678,"startTime":"0","endTime":"0","summary":"Corvus Pharma to present at Cantor Global Healthcare ConferenceCorvus Pharmaceuticals will attend the 2026 Cantor Global Healthcare Conference in New York.Leadership will hold investor one-on-one meet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3mpJR6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","BK4568","LU2210150020.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","SG9999014005.SGD","SG9999014039.USD","BCDF","NDAQ","CRVS","BK4139","BK4585","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874283","title":"Lakeland Fire + Safety Secures Second Consecutive Contract for Foul Weather Gear with the Hong Kong Government Flying Service for Pilots and Engineering Officers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874283?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:31","pubTimestamp":1788438660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5C3L9D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z4B17.USD","BK4202","IE00B66KJ199.SGD","LAKE","BK4568","IE00B7SZL793.SGD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664749708","title":"Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664749708","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664749708?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:25","pubTimestamp":1788438356,"startTime":"0","endTime":"0","summary":"BUZZ-Medicus Pharma surges on Pfizer licensing deal for experimental cancer therapy** Shares of drug developer Medicus PharmaMDCX.Ojump 19.3% to 31 cents premarket** Co says in a regulatory filing that it has entered into a license agreement with PfizerPFE.Nfor rights to develop and commercialize an experimental cancer therapy** Under the deal, Pfizer is eligible to receive more than $1 billion in development, regulatory and sales-based milestone payments, as well as tiered low double-digit royalties on net sales** Pfizer granted Medicus an exclusive global license to develop, manufacture and commercialize PF-08046031, also known as CD228V, an early-stage antibody-drug conjugate targeting melanotransferrin  for all human diseases and disorders** As part of the agreement, Medicus paid Pfizer a non-refundable upfront fee of $12 million and will make an additional $15 million payment on the first anniversary of the deal** Pfizer, in turn, paid Medicus $2 million that must be used to suppo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0XU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1883839398.USD","LU0321505868.SGD","SG9999001176.USD","BK4599","IE00B19Z3581.USD","OZEM","BK4533","LU0306806265.USD","LU1023059063.AUD","LU0289739699.SGD","LU0058720904.USD","SG9999002232.USD","SG9999011175.SGD","SG9999003800.SGD","IE00BBT3K403.USD","LU0234572021.USD","LU1894683348.USD","LU0456855351.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","PFE","BK4568","LU1066051498.USD","SGXZ57979304.SGD","BK4139","BK4581","BK4592","LU0170899867.USD","SG9999013999.USD","LU0321505439.SGD","LU1057294990.SGD","LU1066053197.SGD","LU0225771236.USD","BK4550","LU0225284248.USD","SG9999002224.SGD","SG9999001176.SGD","IE00B3T34201.USD","BK4585","BK4007","IE0002270589.USD","LU0306807586.USD","LU0868494617.USD","BK4534","LU1894683264.USD","BK4588","IE000M9KFDE8.USD","LU2596442595.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874380","title":"AstraZeneca's New Lung Treatment Could Become Market Leader","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874380","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874380?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:11","pubTimestamp":1788437460,"startTime":"0","endTime":"0","summary":"1210 GMT - AstraZeneca's new drug for chronic obstructive pulmonary disease could become a market leader if it proves to be effective across all patient groups, Berenberg analysts say in a research note. Initial trial results released by the U.K. drugmaker earlier this year showed the drug, tozorakimab, delivered benefits both in the primary population of former smokers and in the overall population, and across stages of lung function, the analysts say. Similar drugs from Roche and Sanofi delivered mixed results in trials last year, but AstraZeneca's is expected to work across a broader cohort of COPD patients, they add. \"We would view 30% exacerbation reduction to be a highly positive result and ahead of expectations,\" Berenberg says. Shares rise 1.5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AstraZeneca's New Lung Treatment Could Become Market Leader","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0320765992.SGD","LU0058720904.USD","AZNH","LU0109394709.USD","LU2468319806.SGD","BK4588","LU0029864427.USD","LU2237443382.USD","LU0310800379.SGD","BK4007","LU0432979614.USD","LU2417539215.USD","BK4568","LU0128525929.USD","LU2237443895.HKD","LU2237443978.SGD","AZN","LU2237443465.HKD","LU2089984988.USD","LU1829250122.USD","LU0889565916.HKD","LU0708994859.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2462157665.USD","LU1267930573.SGD","LU2456880835.USD","LU2237443622.USD","BK4585","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287179","title":"Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287179","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287179?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:04","pubTimestamp":1788437065,"startTime":"0","endTime":"0","summary":"Medicus Pharma signs co-development, licensing deal with Pfizer for CD228V antibody-drug conjugateMedicus Pharma entered a co-development and license deal with Pfizer for PF-08046031 (CD228V), an earl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3Mtg02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0306807586.USD","SG9999003800.SGD","BK4007","BK4585","IE00BLSP4239.USD","LU0170899867.USD","LU1057294990.SGD","BK4534","LU0058720904.USD","LU1894683348.USD","PFE","IE00B19Z3581.USD","SG9999001176.SGD","BK4588","LU2596442595.SGD","LU1023059063.AUD","LU0225284248.USD","LU0985481810.HKD","IE00BLSP4452.SGD","BK4581","IE00B3T34201.USD","BK4533","LU0321505439.SGD","BK4550","IE00B19Z3B42.SGD","OZEM","LU1066051498.USD","SG9999002224.SGD","LU0122379950.USD","LU1066053197.SGD","SG9999001176.USD","BK4139","IE000M9KFDE8.USD","LU0456855351.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0321505868.SGD","MDCX","LU0868494617.USD","SG9999011175.SGD","LU0225771236.USD","LU1894683264.USD","LU0306806265.USD","BK4599","IE0002270589.USD","BK4592","BK4568","LU1883839398.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664763871","title":"Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664763871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664763871?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","LU1883839398.USD","BK4533","LU1066051498.USD","IE00BLSP4239.USD","PFE","MDCX","SG9999001176.SGD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0868494617.USD","IE00BBT3K403.USD","BK4568","LU0289739699.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","SG9999011175.SGD","LU0306807586.USD","LU1057294990.SGD","LU1894683264.USD","LU0170899867.USD","LU0225284248.USD","LU0456855351.SGD","LU0985481810.HKD","BK4550","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","SG9999002224.SGD","BK4588","LU1066053197.SGD","BK4534","LU0225771236.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4139","BK4592","SG9999002232.USD","LU0321505868.SGD","BK4599","IE000M9KFDE8.USD","BK4585","IE00B3T34201.USD","LU1894683348.USD","LU2596442595.SGD","OZEM","BK4581","LU0234572021.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664717788","title":"Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664717788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664717788?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0058720904.USD","PFE","IE00B3T34201.USD","SGXZ57979304.SGD","BK4568","BK4599","LU1894683348.USD","IE00BLSP4239.USD","LU0234572021.USD","IE00B19Z3B42.SGD","BK4550","SG9999011175.SGD","BK4533","LU0122379950.USD","BK4007","LU0170899867.USD","LU0321505868.SGD","LU0868494617.USD","LU0289739699.SGD","SG9999001176.USD","BK4592","LU1057294990.SGD","MDCX","LU0306806265.USD","SG9999002224.SGD","LU0225284248.USD","LU1066053197.SGD","BK4585","LU1066051498.USD","IE00BBT3K403.USD","LU1894683264.USD","IE00BLSP4452.SGD","OZEM","LU1883839398.USD","SG9999003800.SGD","SG9999013999.USD","BK4588","SG9999001176.SGD","LU0321505439.SGD","IE00B19Z3581.USD","LU0985481810.HKD","SG9999002232.USD","LU1023059063.AUD","LU0456855351.SGD","BK4534","LU0306807586.USD","IE0002270589.USD","BK4581","LU2596442595.SGD","IE000M9KFDE8.USD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664205871","title":"Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664205871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664205871?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002232.USD","LU0058720904.USD","SG9999013999.USD","SG9999001176.USD","BK4139","BK4588","LU1057294990.SGD","BK4534","IE00BBT3K403.USD","LU1883839398.USD","LU0234572021.USD","LU0985481810.HKD","LU1894683264.USD","LU0321505868.SGD","BK4568","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0456855351.SGD","IE00B19Z3581.USD","LU0225771236.USD","SG9999003800.SGD","LU0868494617.USD","BK4581","SG9999001176.SGD","IE00BLSP4239.USD","LU0122379950.USD","MDCX","LU1066053197.SGD","LU0306807586.USD","LU2596442595.SGD","BK4533","BK4007","LU1066051498.USD","BK4585","LU0321505439.SGD","OZEM","BK4550","LU0306806265.USD","IE00B3T34201.USD","SG9999011175.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU0170899867.USD","LU1023059063.AUD","PFE","LU0225284248.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878125","title":"Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878125","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878125?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:21","pubTimestamp":1788427316,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $108, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","MRNA","BK4533","BK4532","BK4548","BK4588","MRNX","BK4534","BK4568","IDNA","MRNY","BK4139","WDNA","BK4501","GNOM","BK4551","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664982743","title":"Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664982743","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664982743?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:20","pubTimestamp":1788423613,"startTime":"0","endTime":"0","summary":"Transgene jumps 20% on positive cancer vaccine data in early trialSept 3 (Reuters)-TransgeneTRNG.PAshares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL6N44V0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","GNOM","MRNX","BK4532","BK4501","BK4533","BK4139","BK4551","IDNA","MRNY","WDNA","BK4585","LGHT","BK4534","BK4568","BK4588","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581844","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581844","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581844?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:41","pubTimestamp":1788385260,"startTime":"0","endTime":"0","summary":"Nu Holdings Cl A              NU    80,770,304     15.40     0.94      6.50. Hewlett Packard Ent          HPE    59,507,796     51.83     0.96      1.89. Dell Technologies Cl C      DELL    36,437,563    492.20    67.20     15.81. Bank of America              BAC    27,678,568     62.60     0.61      0.98. Blue Owl Capital             OWL    26,783,252     11.60    -0.08     -0.68","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU1894683264.USD","LU0106831901.USD","UYG","IYG","IE00B19Z3B42.SGD","SG9999001176.USD","BK4568","LU0053666078.USD","FNCL","DINT","IE00B19Z3581.USD","LU0256863811.USD","LU1291159041.SGD","BK4561","OZEM","IE00BBT3K403.USD","VFH","BK4599","IE00B1BXHZ80.USD","LU0130103400.USD","LU1066053197.SGD","PFE","PATX","ARMH","LU0321505868.SGD","TFNS","IE00BFXG1179.USD","FTXO","PATH","LU0683600562.USD","BAC","AADR","BK4504","LU1861559042.SGD","CVY","LU0310800965.SGD","BK4604","DIVL","IE00BLSP4239.USD","LU0321505439.SGD","IYF","BK4533","BK4539","SAPH","SG9999003800.SGD","APIE","XLF","LU1883839398.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844849","title":"Novavax Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844849?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:27","pubTimestamp":1788384420,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rallied 1.98% to $10.32 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.45% to 26,217.83 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.This was the stock's fourth consecutive day of gains.Novavax Inc. closed 13.78% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Pfizer Inc.  rose 1.65% to $29.02, and Merck & Co. Inc.  rose 1.19% to $151.64.Trading volume  eclipsed its 50-day average volume of 4.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4547","BK4588","NVAX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844855","title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844855","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844855?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:24","pubTimestamp":1788384240,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  rallied 2.26% to $1.36 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.45% to 26,217.83 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.This was the stock's second consecutive day of gains.Inovio Pharmaceuticals Inc. closed 54.35% below its 52-week high of $2.98, which the company reached on September 9th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 1.65% to $29.02.Trading volume  eclipsed its 50-day average volume of 3.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","BK4583","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664484146","title":"Novavax to Present at Cantor Global Healthcare Conference in Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664484146","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664484146?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:01","pubTimestamp":1788382886,"startTime":"0","endTime":"0","summary":"Novavax to present at Cantor Global Healthcare Conference in fireside chatNovavax management will join the Cantor Global Healthcare Conference in New York on Sept. 9, 2026, for a 9:45 a.m. EDT firesid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2420FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","IYF","LU2456880835.USD","LU0130102774.USD","LU0203345920.USD","LU0314106906.USD","LU2236285917.USD","NVAX","LU0203347892.USD","TFNS","LU1244550577.SGD","LU0320765646.SGD","BK4585","LU0170899867.USD","LU0310800965.SGD","BK4504","BK4534","BK4547","BK4588","LU0980610538.SGD","LU0106831901.USD","LU1074936037.SGD","BK4566","LU1162221912.USD","LU0477156953.USD","LU1791807156.HKD","BK4559","LU0130517989.USD","BK4139","FTXO","LU1267930227.SGD","BK4207","LU1144417596.USD","LU1244550221.USD","LU0098860793.USD","LU1366192091.USD","LU2125154935.USD","LU2462157665.USD","LU0072461881.USD","LU0648001328.SGD","LU1201861249.SGD","LU2360032135.SGD","LU0128525689.USD","LU0162691827.USD","LU1668664300.SGD","LU1244550494.USD","BK4568","LU0052756011.USD","LU2125154778.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664413058","title":"Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664413058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664413058?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:35","pubTimestamp":1788381300,"startTime":"0","endTime":"0","summary":"DJ Pfizer Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Pfizer Inc.  rallied 1.65% to $29.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.This was the stock's third consecutive day of gains.Pfizer Inc. closed 0.24% below its 52-week high of $29.09, which the company achieved on September 1st.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Eli Lilly & Co.  rose 0.01% to $1,160.08, and Abbott Laboratories  rose 1.41% to $110.47.Trading volume  remained 3.5 million below its 50-day average volume of 42.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","SGXZ57979304.SGD","LU1066053197.SGD","LU0058720904.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4599","LU2596442595.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","LU1894683264.USD","LU0225771236.USD","LU1023059063.AUD","LU0234572021.USD","BK4534","LU0122379950.USD","IE000M9KFDE8.USD","LU0225284248.USD","SG9999002232.USD","LU0170899867.USD","SG9999002224.SGD","PFE","LU0289739699.SGD","BK4585","BK4588","SG9999011175.SGD","BK4007","IE00BLSP4239.USD","LU0306807586.USD","SG9999003800.SGD","BK4581","LU1057294990.SGD","IE00B19Z3581.USD","BK4568","BK4592","BK4550","SG9999001176.USD","IE00B3T34201.USD","LU1894683348.USD","OZEM","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","SG9999013999.USD","LU0321505868.SGD","BK4533","IE00BBT3K403.USD","LU0306806265.USD","LU0868494617.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841391","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841391?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:34","pubTimestamp":1788381240,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  advanced 1.41% to $110.47 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.The stock's rise snapped a two-day losing streak.Abbott Laboratories closed 19.65% short of its 52-week high of $137.49, which the company reached on September 22nd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Pfizer Inc.  rose 1.65% to $29.02, and Merck & Co. Inc.  rose 1.19% to $151.64.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211815571.USD","IHI","LU1023059063.AUD","SG9999002224.SGD","IE0002141913.USD","LU1061106388.HKD","LU1670627923.USD","LU1691799644.USD","LU2112291526.USD","SG9999002232.USD","BK4585","LU0289739699.SGD","LU1057294990.SGD","LU1721429402.USD","IE00BJT1NW94.SGD","LU2089984988.USD","TMED","LU2237957811.SGD","BK4592","LU0070302665.USD","LU0122379950.USD","LU0208291251.USD","LU1721429741.USD","LU0320765489.SGD","BK4568","LU1914381329.SGD","LU0114720955.EUR","LU0882574055.USD","LU2133065610.SGD","SG9999004303.SGD","LU0211331839.USD","IE00BFTCPJ56.SGD","LU1989763427.SGD","LU0234572021.USD","BK4588","IE00BJJMRZ35.SGD","ABT","LU0266013472.USD","LU2468319806.SGD","LU0868494617.USD","SGXZ41872573.SGD","IE0009355771.USD","LU0432979614.USD","LU1989763690.USD","SGXZ23171101.USD","BK4533","LU0058720904.USD","IE00B4R5TH58.HKD","BK4082","LU2237957902.USD","BK4581","PJP","BK4566","LU0170899867.USD","LU1670628061.USD","BK4504","LU2324357040.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664499688","title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664499688","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664499688?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:13","pubTimestamp":1788380002,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O'Day disposes of USD 2.23 million in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 14,000 common shares on Sep. 1, 2026.Sales priced at about $147.51 to $1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5HTC5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4585","LU0965509283.SGD","LU1057294990.SGD","LU0965509101.SGD","IBBQ","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1571399168.USD","LU1674673691.USD","BK4583","TMED","GILD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1066051498.USD","LU1839511570.USD","IE0002270589.USD","LU1934455277.USD","LU2357627491.SGD","TBXU","LU0289739699.SGD","LU0882574055.USD","BK4578","LU1066053197.SGD","SG9999015978.USD","LU1934455194.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","IBB","LU0122379950.USD","LU0861579265.USD","LU1061106388.HKD","LU0823416689.USD","LU2087621335.USD","LU0889565916.HKD","BIB","LU2324357040.USD","IE00BSNM7G36.USD","SG9999015952.SGD","LU0320765992.SGD","LU0965508806.USD","LU0058720904.USD","MEDI","LU1023059063.AUD","LU0109394709.USD","BMED","BK4568","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664435168","title":"Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664435168","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664435168?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:31","pubTimestamp":1788366679,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 1 study called “A PHASE 1 STUDY TO EVAL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-new-asthma-candidate-pf-08103402-enters-phase-1-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-new-asthma-candidate-pf-08103402-enters-phase-1-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225284248.USD","LU0456855351.SGD","LU1023059063.AUD","BK4534","LU1894683264.USD","SG9999002224.SGD","IE0002270589.USD","SG9999002232.USD","BK4585","LU0289739699.SGD","LU1057294990.SGD","IE00BBT3K403.USD","PFE","BK4592","LU0122379950.USD","LU1066053197.SGD","LU0321505868.SGD","BK4568","LU1894683348.USD","SG9999013999.USD","SG9999011175.SGD","IE00BLSP4239.USD","LU2596442595.SGD","IE000M9KFDE8.USD","SG9999003800.SGD","BK4007","LU0234572021.USD","LU0225771236.USD","BK4588","IE00B3T34201.USD","OZEM","SG9999001176.USD","BK4533","LU0058720904.USD","LU1066051498.USD","IE00BLSP4452.SGD","LU0306806265.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","BK4581","BK4550","IE00B19Z3B42.SGD","LU0170899867.USD","LU0321505439.SGD","BK4599","LU0306807586.USD","LU0985481810.HKD","LU1883839398.USD","LU0868494617.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":220,"code":"91000000","status":"200"}]}}